These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease. Binion DG; Rafiee P Gastroenterology; 2009 Feb; 136(2):400-3. PubMed ID: 19111728 [No Abstract] [Full Text] [Related]
23. [Endothelial dysfunction and diabetes: possible role in kidney damage]. Tesauro M; Leo R; Lauro R; Cardillo C G Ital Nefrol; 2009; 26 Suppl 46():62-70. PubMed ID: 19644821 [TBL] [Abstract][Full Text] [Related]
24. Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis. Sandberg WJ; Halvorsen B; Yndestad A; Smith C; Otterdal K; Brosstad FR; Frøland SS; Olofsson PS; Damås JK; Gullestad L; Hansson GK; Oie E; Aukrust P Circ Res; 2009 Jan; 104(1):60-8. PubMed ID: 19023130 [TBL] [Abstract][Full Text] [Related]
26. Down regulation of aortic nitric oxide and antioxidant systems in chronic alcohol-induced hypertension in rats. Husain K; Vazquez-Ortiz M; Lalla J Hum Exp Toxicol; 2007 May; 26(5):427-34. PubMed ID: 17623767 [TBL] [Abstract][Full Text] [Related]
29. A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism. Nakagawa T Clin Nephrol; 2009 Feb; 71(2):103-9. PubMed ID: 19203501 [TBL] [Abstract][Full Text] [Related]
34. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985 [TBL] [Abstract][Full Text] [Related]
35. The emerging role of VEGF in diabetic kidney disease. Khamaisi M; Schrijvers BF; De Vriese AS; Raz I; Flyvbjerg A Nephrol Dial Transplant; 2003 Aug; 18(8):1427-30. PubMed ID: 12897074 [No Abstract] [Full Text] [Related]
36. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties. Levine DZ Clin Sci (Lond); 2008 Jan; 114(2):109-18. PubMed ID: 18062776 [TBL] [Abstract][Full Text] [Related]
37. Do adenosine receptors offer new therapeutic options for diabetic nephropathy? San Martín R; Valladares D; Roa H; Troncoso E; Sobrevia L Curr Vasc Pharmacol; 2009 Oct; 7(4):450-9. PubMed ID: 19485887 [TBL] [Abstract][Full Text] [Related]
38. Activating SIRT1: a new strategy to prevent atherosclerosis? Brandes RP Cardiovasc Res; 2008 Nov; 80(2):163-4. PubMed ID: 18784217 [No Abstract] [Full Text] [Related]
39. Glomerular endothelial dysfunction in type 2 diabetes mellitus. Futrakul N; Butthep P; Futrakul P; Sittipreja V Ren Fail; 2006; 28(6):523-4. PubMed ID: 16928624 [No Abstract] [Full Text] [Related]